These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9174719)

  • 41. Radioiodine therapy in differentiated thyroid carcinoma.
    Salvatori M; Rufini V; Garganese MC; Di Giuda D
    Rays; 2000; 25(2):221-38. PubMed ID: 11370540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spindle and giant cell carcinoma of the thyroid: report of a five-year survival after lobectomy and postoperative irradiation.
    Spiro RH; Daniello N
    J Surg Oncol; 1979 Dec; 12(4):385-9. PubMed ID: 522492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiated thyroid carcinoma in a juvenile patient.
    Khan MU; Nawaz MK; Saadullah M; Syed AA; Hussain R; Azhar R; Shah MA
    Clin Nucl Med; 2008 May; 33(5):319-20. PubMed ID: 18431142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
    Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
    Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
    Lin JD; Chao TC; Hsueh C
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
    Heron DE; Karimpour S; Grigsby PW
    Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
    Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Radioiodine therapy in differentiated thyroid gland carcinoma].
    Schicha H; Dietlein M
    Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
    Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
    Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoclastome-like giant cell thyroid carcinoma controlled by intensive radiation and adriamycin, in a patient with meningioma and multiple myeloma treated by radiation and cytoxan.
    Vizel-Schwartz M
    J Surg Oncol; 1981; 17(1):57-61. PubMed ID: 7230831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiating anaplastic thyroid carcinomas.
    Nusynowitz ML
    J Nucl Med; 1991 Jul; 32(7):1363-4. PubMed ID: 2066791
    [No Abstract]   [Full Text] [Related]  

  • 52. Combined therapy for undifferentiated giant and spindle cell carcinoma of the thyroid.
    Andersson T; Biörklund A; Landberg T; Akerman M; Aspegren K; Ingemansson S
    Acta Otolaryngol; 1977; 83(3-4):372-7. PubMed ID: 855660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Differentiated epitheliomas of the thyroid].
    Parmentier C; Schlumberger M; Charbord P; Travagli JP; Caillou B; Lacour J
    Rev Prat; 1982 May; 32(29):1981-2 passim. PubMed ID: 7112010
    [No Abstract]   [Full Text] [Related]  

  • 54. Response to undifferentiated thyroid carcinoma to combined modality treatment.
    Brun JG; Barre Y; Barre T; Mogenet M; Reynier J
    World J Surg; 1979 Aug; 3(4):517-20. PubMed ID: 516770
    [No Abstract]   [Full Text] [Related]  

  • 55. Surgical strategies and methods for the treatment of metastasizing medullary thyroid carcinoma.
    Buhr HJ; Kallinowski F; Herfarth C
    Recent Results Cancer Res; 1992; 125():147-65. PubMed ID: 1448596
    [No Abstract]   [Full Text] [Related]  

  • 56. [Present-day therapeutic methods in thyroid carcinoma].
    Skrzypek J; Wasylewski A
    Pol Przegl Chir; 1979 Jan; 51(1):81-5. PubMed ID: 461247
    [No Abstract]   [Full Text] [Related]  

  • 57. Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.
    Haymart MR; Esfandiari NH; Stang MT; Sosa JA
    Endocr Rev; 2017 Aug; 38(4):351-378. PubMed ID: 28633444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. External radiotherapy and radionuclide in the treatment of thyroid cancer.
    Tubiana M
    World J Surg; 1981 Jan; 5(1):75-84. PubMed ID: 7233957
    [No Abstract]   [Full Text] [Related]  

  • 59. [Proposal for a protocol of a national and multidisciplinary study of medullary cancer of the thyroid].
    Trotoux J
    Rev Laryngol Otol Rhinol (Bord); 1985; 106(1):41-3. PubMed ID: 4001630
    [No Abstract]   [Full Text] [Related]  

  • 60. Case 37-1979: Thyroid carcinoma.
    Katsas AG
    N Engl J Med; 1980 Feb; 302(8):467. PubMed ID: 7351958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.